
Cellectar BioSciences (CLRB) P/E Ratio
P/E Ratio as of Dec 15, 2025: -0.30
Average-0.3230
Median-0.3400
Minimum-0.3800
Maximum-0.2700
-0.30
0.03 (11.11%)past month
The P/E ratio for Cellectar BioSciences (CLRB) is -0.30 as of Dec 15, 2025. This represents a increase of 15.38% compared to its 12-month average P/E ratio of -0.26. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Cellectar BioSciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Cellectar BioSciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Cellectar BioSciences to industry peers.
Cellectar BioSciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Cellectar BioSciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Cellectar BioSciences to industry peers.
Cellectar BioSciences (CLRB) P/E Ratio Insights
See Cellectar BioSciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Cellectar BioSciences (CLRB)
Order type
Buy in
Order amount
Est. shares
0 shares
Cellectar BioSciences (CLRB) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Dec 1, 2025 | $3.73 | -0.35 |
| Nov 3, 2025 | $3.30 | -0.16 |
| Oct 1, 2025 | $5.77 | -0.28 |
| Sep 2, 2025 | $4.82 | -0.24 |
| Aug 1, 2025 | $4.72 | -0.21 |
| Jul 1, 2025 | $4.86 | -0.22 |
| Jun 2, 2025 | $7.863 | -0.35 |
| May 1, 2025 | $7.926 | -0.35 |
| Apr 1, 2025 | $8.76 | -0.39 |
| Mar 3, 2025 | $8.286 | -0.18 |
| Feb 3, 2025 | $7.86 | -0.17 |
| Jan 2, 2025 | $9.747 | -0.21 |
Cellectar BioSciences (CLRB) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.30 | +50.00% |
| 2024 | -0.20 | -75.00% |
| 2023 | -0.80 | +627.27% |
| 2022 | -0.11 | -92.72% |
| 2021 | -1.51 | -33.77% |
| 2020 | -2.28 | — |
FAQs About Cellectar BioSciences (CLRB) P/E ratio
The latest P/E ratio of Cellectar BioSciences (CLRB) is -0.30, as of Dec 15, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Cellectar BioSciences’s last 12-month average P/E ratio is -0.26, compared to its current P/E ratio of -0.30. This reflects a increase of 15.38%.
Cellectar BioSciences’s current P/E ratio of -0.30 is higher than its last 12-month average P/E of -0.26. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Cellectar BioSciences’s average P/E ratio over the last 3 years is -0.55. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Cellectar BioSciences’s average P/E ratio over the last 5 years is -0.94. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.